Name: SLE Management: What Are the New Agents That Have Been Approved or Have Very Promising Preliminary Results? What Is the Challenge of Long-Lived Plasma Cells? What Are the Benefits of SGLT2i on Renal and Cardiovascular Outcomes?
Uploaded: 2021-07-27T08:02:03.808929+00:00
Duration: 36 min 46 s

Cleveland Clinic Department of Rheumatic and Immunologic Disease

Cleveland Clinic Medical Specialty Institute offers expert diagnosis, treatment and rehabilitation for bone, joint or connective tissue disorders and rheumatic and immunologic diseases.